1st half day 2nd half day dash 1st half month 2nd half month dash 1st digit year 2nd digit year 3rd digit year last digit year

Flibanserin Could Be Rival To Intrinsa



Written by Stuart Stevens | Friday, 18 May 2007 | There are 2 comments

The Flibanserin drug works in a completely different way to Intrinsa...

When Viagra came onto the market and drug companies realised how much cash there was in treating male erectile dysfunction, within the space of a few years two competitors had launched their rival products meaning that now men have a big choice when it comes to erectile dysfunction medication. It looks like the female sexual dysfunction market could be going the same way. Intrinsa that is being dubbed ‘the female Viagra’ and which is now for sale in the United Kingdom is the first medication ever to be fully licensed for the treatment of female sexual problems. It is actually administered by the way of a patch that is worn on the skin and releases very small amounts of testosterone in to the bloodstream.

Flibanserin Could Be Rival To Intrinsa

Hot on the heels of Intrinsa are many other research projects to help women with female sexual dysfunction but one of the most promising ones which we have been following for some time at Ukmedix News is Flibanserin which like many drugs was not originally tested for female sexual dysfunction but for something completely unrelated.

According to experts the Flibanserin drug works in a completely different way to Intrinsa in that it actively targets the zones of a woman’s brain that control pleasure and does not interfere with hormone levels. Originally the drug had been tested as an antidepressant and the testing was about to be discontinued when a bright researcher noted that many of the women using it reported that while it was not effective as an antidepressant they had noticed that their libido had increased significantly.

In the United States studies are going to start soon involving hundreds of women between the years of 18 and 45. If the drug works well the testing may be enlarged to include men as well, but for now the researchers are limiting their clinical trials to females. Ukmedix News reckon that Flibanserin is one to watch for the future.

© 2012 This content has been exclusively written by UKMedix [request source information]
ChatterBack with UKMedixGoto ChatterBack with UKMedix

There are 2 comments on this article.

On November 17, 2009 at 16:34
paddy said:

this new drug will not just another gimmick like pt 141

Separate Comment
On November 17, 2009 at 22:54
logic said:

time will tell.

Separate Comment
Name :  *
Comment :  *
  Secure Image
Code :  * (please enter the code above)
 

Fields marked with  * are required.

Chatter Box Top
Chatter Box Bottom